Pier 88 Investment Partners’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $800K | Buy |
57,150
+12,240
| +27% | +$171K | 0.15% | 65 |
|
2025
Q1 | $611K | Sell |
44,910
-500
| -1% | -$6.8K | 0.12% | 80 |
|
2024
Q4 | $925K | Sell |
45,410
-13,760
| -23% | -$280K | 0.18% | 56 |
|
2024
Q3 | $1.72M | Sell |
59,170
-10,200
| -15% | -$297K | 0.38% | 36 |
|
2024
Q2 | $1.61M | Buy |
69,370
+29,400
| +74% | +$683K | 0.36% | 42 |
|
2024
Q1 | $820K | Sell |
39,970
-5,270
| -12% | -$108K | 0.2% | 46 |
|
2023
Q4 | $971K | Sell |
45,240
-5,460
| -11% | -$117K | 0.24% | 54 |
|
2023
Q3 | $1.05M | Buy |
50,700
+3,020
| +6% | +$62.3K | 0.26% | 63 |
|
2023
Q2 | $1.41M | Buy |
47,680
+4,840
| +11% | +$143K | 0.35% | 51 |
|
2023
Q1 | $987K | Buy |
42,840
+7,600
| +22% | +$175K | 0.24% | 55 |
|
2022
Q4 | $980K | Buy |
35,240
+23,150
| +191% | +$644K | 0.24% | 54 |
|
2022
Q3 | $371K | Sell |
12,090
-990
| -8% | -$30.4K | 0.09% | 79 |
|
2022
Q2 | $385K | Buy |
13,080
+13,070
| +130,700% | +$385K | 0.09% | 85 |
|
2022
Q1 | $0 | Sell |
10
-33,070
| -100% | – | ﹤0.01% | 90 |
|
2021
Q4 | $1.48M | Buy |
33,080
+14,200
| +75% | +$634K | 0.31% | 64 |
|
2021
Q3 | $952K | Buy |
18,880
+4,760
| +34% | +$240K | 0.29% | 73 |
|
2021
Q2 | $1.11M | Buy |
14,120
+6,560
| +87% | +$515K | 0.32% | 74 |
|
2021
Q1 | $432K | Sell |
7,560
-5,265
| -41% | -$301K | 0.15% | 98 |
|
2020
Q4 | $1.07M | Sell |
12,825
-22,970
| -64% | -$1.92M | 0.35% | 53 |
|
2020
Q3 | $1.28M | Sell |
35,795
-16,514
| -32% | -$591K | 0.39% | 53 |
|
2020
Q2 | $1.27M | Buy |
52,309
+4,609
| +10% | +$111K | 0.36% | 69 |
|
2020
Q1 | $835K | Buy |
47,700
+5,700
| +14% | +$99.8K | 0.3% | 57 |
|
2019
Q4 | $732K | Buy |
42,000
+1,390
| +3% | +$24.2K | 0.29% | 47 |
|
2019
Q3 | $622K | Buy |
40,610
+12,960
| +47% | +$199K | 0.24% | 65 |
|
2019
Q2 | $574K | Sell |
27,650
-8,280
| -23% | -$172K | 0.24% | 70 |
|
2019
Q1 | $834K | Buy |
35,930
+9,800
| +38% | +$227K | 0.38% | 48 |
|
2018
Q4 | $540K | Sell |
26,130
-11,800
| -31% | -$244K | 0.27% | 52 |
|
2018
Q3 | $825K | Buy |
+37,930
| New | +$825K | 0.36% | 41 |
|